Design of novel hypoxia-targeting IDO hybrid inhibitors conjugated with an unsubstituted L-TRP as an IDO affinity moiety.
Design of novel hypoxia-targeting IDO hybrid inhibitors conjugated with an unsubstituted L-TRP as an IDO affinity moiety.
复制标题
DOI:
10.1007/978-1-4419-1241-1_60
复制
发表时间:
2010
影响因子:
--
通讯作者:
H. Nakashima;Kazuhiro Ikkyu;K. Nakashima;Keiichiro Sano;Y. Uto;Eiji Nakata;H. Nagasawa;H. Sugimoto;Y. Shiro;Y. Nakagawa;H. Hori
中科院分区:
文献类型:
--
作者:
H. Nakashima;Kazuhiro Ikkyu;K. Nakashima;Keiichiro Sano;Y. Uto;Eiji Nakata;H. Nagasawa;H. Sugimoto;Y. Shiro;Y. Nakagawa;H. Hori
We presented here design, syntheses and inhibitory activities of novel hypoxia-targeting IDO hybrid inhibitors conjugated with an unsubstituted L-Trp as an IDO affinity moiety without inhibitor 1MT, such as L-Trp-TPZ hybrids1(TX-2274),2(UTX-3),3(UTX-4), and4(UTX-2). TPZ-monoxide hybrids1and3were good competitive IDO inhibitors, while TPZ hybrids2and4were uncompetitive IDO inhibitors. Among them TPZ-monoxide hybrid1have the strongest IDO inhibitory activity. It suggests that TPZ-monoxide hybrids1and3are able to bind the active site of IDO, TPZ hybrids2and4are able to bind the enzyme-substrate complex. We proposed the possible mechanism of action of TPZ hybrid2that may first affect as a hypoxic cytotoxin, and then metabolized to TPZ-monoxide hybrid1, which may do as an IDO inhibitor more effectively than its parent TPZ hybrid2.